First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.44 USD -7.11% Market Closed
Updated: Apr 26, 2024

ADC Therapeutics SA
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Total Other Income Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Total Other Income
$5.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Other Income
$71.8m
CAGR 3-Years
124%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Other Income
CHf768k
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Total Other Income
CHf4.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Total Other Income?
Total Other Income
5.9m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Total Other Income amounts to 5.9m USD.

What is ADC Therapeutics SA's Total Other Income growth rate?
Total Other Income CAGR 1Y
1 377%

Over the last year, the Total Other Income growth was 1 377%.